(Q40869486)

English

Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation

scientific article published on June 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 September 2017

Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation (English)

1 reference

Europe PubMed Central

24 September 2017

1 reference

based on heuristic

inferred from title

author name string

Chisi JE

1

1 reference

Europe PubMed Central

24 September 2017

Briscoe CV

2

1 reference

Europe PubMed Central

24 September 2017

Ezan E

3

1 reference

Europe PubMed Central

24 September 2017

Genet R

4

1 reference

Europe PubMed Central

24 September 2017

Riches AC

5

1 reference

Europe PubMed Central

24 September 2017

Wdzieczak-Bakala J

6

1 reference

Europe PubMed Central

24 September 2017

language of work or name

0 references

publication date

1 June 2000

1 reference

Europe PubMed Central

24 September 2017

British Journal of Haematology

1 reference

Europe PubMed Central

24 September 2017

109

1 reference

Europe PubMed Central

24 September 2017

3

1 reference

Europe PubMed Central

24 September 2017

563-570

1 reference

Europe PubMed Central

24 September 2017

In vivo effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP on haemopoiesis of mice treated with 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

Adverse effects of the angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline: a new marker of chronic angiotensin-converting enzyme inhibition.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

Captopril and lisinopril suppress production of interleukin-12 by human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

Worsening of anemia induced by long-term use of captopril in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02073.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2000.02073.X

1 reference

Europe PubMed Central

24 September 2017

1 reference

Europe PubMed Central

24 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40869486&oldid=1909359591"